A Win For Aquestive Therapeutics, Inc.
Mon, Feb 02, 2026 at 08:04 PM
Aquestive Therapeutics, Inc. (AQST:NASDAQ) jumped higher at $4.1, a gain of 39%. On Mon, Feb 02, 2026, AQST:NASDAQ hit a New 2-Week High of $4.1. The stock got featured on our News Catalysts scanner on Mon, Feb 02, 2026 at 03:02 PM in the 'BIOTECH' category. From Tue, Jan 20, 2026, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Mon, Oct 20, 2025 at $7.55 with a volume of 3M+.
About Aquestive Therapeutics, Inc. (AQST:NASDAQ)
Aquestive Therapeutics Inc is a specialty pharmaceutical company that advances and commercializes medicines to solve critical health care problems.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 425%
- F45 Training Holdings Inc. (FXLV:NYSE), 350%
- DarkIris Inc. (DKI:NASDAQ), 185.29%
- Fusemachines Inc. (FUSE:NASDAQ), 70.89%
- Republic Power Group Ltd (RPGL:NASDAQ), 59.09%
- Top Win International Limited (SORA:NASDAQ), 58.19%
- X3 Holdings Co., Ltd. (XTKG:NASDAQ), 55.48%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 45.85%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 39.03%
- Aquestive Therapeutics, Inc. (AQST:NASDAQ), 38.98%